Hydrogel Chip Microenvironment for Dynamic Tumor Drug Testing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer research models fail to accurately simulate the dynamic mechanical microenvironment of tumors, particularly in non-small cell lung cancer, due to their reliance on static extracellular matrix models that do not consider the impact of non-tumor cells and cannot replicate the complex physiological conditions of the lung in vivo, leading to inadequate drug testing and understanding of cancer progression.
Innovation Solution
A system comprising a chip with a hydrogel and laser module to mimic the cellular microenvironment, allowing for dynamic mechanical stimulation of three-dimensional cell cultures, including tumor and non-tumor cells, to simulate the effects of drug administration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If static extracellular matrix models are used, then the model structure is simple and easy to manufacture, but the model fails to replicate the dynamic mechanical microenvironment and cannot accurately simulate tumor progression
Solution Approach 1:
The patent applies the dynamics principle by transitioning from static to dynamic extracellular matrix models. The hydrogel-based system enables cyclic mechanical deformation that mimics the dynamic mechanical properties of the tumor microenvironment, allowing the model to accurately simulate tumor cell behavior, migration, and response to therapy while maintaining manufacturability through standardized hydrogel fabrication processes.
2Productivity
If two-dimensional monolayer cell cultures are used, then the culture system is simple and high-throughput, but the system cannot capture the three-dimensional architecture and cellular interactions present in vivo
Solution Approach 1:
The patent applies the dimensionality change principle by transitioning from two-dimensional monolayer cultures to three-dimensional hydrogel-based models. This enables the system to capture the spatial architecture, cell-cell interactions, and matrix-cell interactions present in vivo while maintaining high-throughput capability through microplate-based formats that allow parallel processing of multiple conditions.
Solution Approach 2:
The patent applies the composite materials principle by using hydrogel matrices that combine multiple functional components (collagen, gelatin, hyaluronic acid, and synthetic polymers) to create a composite extracellular matrix system. This composite structure provides both the mechanical properties needed for high-throughput experimentation and the biological fidelity to represent the complex tumor microenvironment.
3Ease of operation
If conventional in vitro drug testing models are used, then the testing process is straightforward, but the models fail to replicate the complex physiological conditions and dynamic mechanical properties of the lung in vivo
Solution Approach 1:
The patent applies the dynamics principle by incorporating cyclic mechanical deformation into the hydrogel matrix to replicate the dynamic mechanical environment of the lung. This enables conventional drug testing protocols to be performed within a physiologically relevant context, improving predictive accuracy while maintaining operational simplicity through automated mechanical stimulation systems.
Data Source
AI summary
A system for mimicking cellular microenvironment is provided and includes a chip, a hydrogel, and cells in contact with the hydrogel. The chip includes a first carrier having a pore and a second carrier coupled to the first carrier. The hydrogel is disposed in the pore and includes extracellular matrix. Also provided is a method for evaluating cell development, including providing the system for mimicking cellular microenvironment; providing a stimulation to a responsive hydrogel; and evaluating the cell development. Further provided is a method for evaluating drug therapy effectiveness, including providing the system for mimicking cellular microenvironment; administering the drug to the cells; and evaluating drug therapy effectiveness.